Paola Parrella

San Giovanni Rotondo, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 45 publications

Advances and challenges in biomarker guided management of triple-negative breast cancer in the era of neoadjuvant chemo-immunotherapy.

Advances and challenges in biomarker guided management of triple-negative breast cancer in the era of neoadjuvant chemo-immunotherapy.

Journal: Frontiers in oncology

Published: March 30, 2026

Early Immune Signature Features, Including TLR2 and TLR4 Expression, Are Associated with Complete Remission After CD19 CAR-T Cell Therapy.

Early Immune Signature Features, Including TLR2 and TLR4 Expression, Are Associated with Complete Remission After CD19 CAR-T Cell Therapy.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: March 25, 2026

KRAS Mutations in Colorectal Adenocarcinoma: Incidence and Association with Histological Features with Particular Reference to Gly12Asp in a Multicenter GIPAD Real-World Study.

KRAS Mutations in Colorectal Adenocarcinoma: Incidence and Association with Histological Features with Particular Reference to Gly12Asp in a Multicenter GIPAD Real-World Study.

Journal: Cancers

Published: May 29, 2025

Development of a microRNA-based prognostic model for accurate prediction of distant metastasis in breast cancer patients.

Development of a microRNA-based prognostic model for accurate prediction of distant metastasis in breast cancer patients.

Journal: Breast cancer research : BCR

Published: March 17, 2025

Comprehensive Molecular Screening by Next Generation Sequencing of Gastrointestinal Stromal Tumors (GISTs): In Silico Analysis and Classification of Rare KIT Exon 11 Mutations.

Comprehensive Molecular Screening by Next Generation Sequencing of Gastrointestinal Stromal Tumors (GISTs): In Silico Analysis and Classification of Rare KIT Exon 11 Mutations.

Journal: Cancer medicine

Published: January 21, 2025

Tumor Suppressor miR-27a-5p and Its Significance for Breast Cancer.

Tumor Suppressor miR-27a-5p and Its Significance for Breast Cancer.

Journal: Biomedicines

Published: October 23, 2024

Colorectal adenosquamous carcinoma: genomic profiling of a rare histotype of colorectal cancer.

Colorectal adenosquamous carcinoma: genomic profiling of a rare histotype of colorectal cancer.

Journal: Virchows Archiv : an international journal of pathology

Published: September 12, 2022

Editorial: Tumor microenvironment signaling networks in pathophysiology and therapeutics.

Editorial: Tumor microenvironment signaling networks in pathophysiology and therapeutics.

Journal: Frontiers in oncology

Published: August 01, 2022

Clinical efficacy of sequential treatments in KRASG12C-mutant metastatic colorectal cancer: findings from a real-life multicenter Italian study (CRC-KR GOIM).

Clinical efficacy of sequential treatments in KRASG12C-mutant metastatic colorectal cancer: findings from a real-life multicenter Italian study (CRC-KR GOIM).

Journal: ESMO open

Published: June 29, 2022

Androgen receptor in breast cancer: The "5W" questions.

Androgen receptor in breast cancer: The "5W" questions.

Journal: Frontiers in endocrinology

Published: June 24, 2022

The Interplay between PARP Inhibitors and Immunotherapy in Ovarian Cancer: The Rationale behind a New Combination Therapy.

The Interplay between PARP Inhibitors and Immunotherapy in Ovarian Cancer: The Rationale behind a New Combination Therapy.

Journal: International journal of molecular sciences

Published: March 05, 2022

ALYREF, a novel factor involved in breast carcinogenesis, acts through transcriptional and post-transcriptional mechanisms selectively regulating the short NEAT1 isoform.

ALYREF, a novel factor involved in breast carcinogenesis, acts through transcriptional and post-transcriptional mechanisms selectively regulating the short NEAT1 isoform.

Journal: Cellular and molecular life sciences : CMLS

Published: December 01, 2021

Showing 1-12 of 45

Last Updated: 09/26/2026